These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 930234)

  • 1. Cellular immune reactions in patients with bronchogenic carcinoma before and after radio-, chemo- and immunotherapy.
    Gropp C; Havemann K
    Z Immunitatsforsch Immunobiol; 1977 Sep; 153(3):236-47. PubMed ID: 930234
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemo-immunotherapy for unresectable bronchogenic carcinoma.
    Sarna GP; Lowitz BB; Haskell CM; Dorey FJ; Cline MJ
    Cancer Treat Rep; 1978 May; 62(5):681-7. PubMed ID: 350397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoimmunotherapy of small cell bronchogenic carcinoma.
    Holoye PY; Samuels ML; Smith T; Sinkovics JG
    Cancer; 1978 Jul; 42(1):34-40. PubMed ID: 208755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunotherapy of carcinoma of the lung].
    Sega E; Mineo TC; Rea SR; Sega FM; Ricci C
    Recenti Prog Med; 1978 Mar; 64(3):293-309. PubMed ID: 351751
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunological status and surgery of cancer of the lung. Prognostic aspects and therapeutic prospects].
    Fegiz G; Di Paola M; Colizza S
    Minerva Chir; 1977 Jun; 32(11):677-82. PubMed ID: 329159
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of delayed hypersensitivity to tuberculin in 130 cancerous adults. Effects of BCG].
    Israel L; Mawas C; Bouvrain A; Mannoni P; Sors C
    Pathol Biol; 1967; 15(11):597-601. PubMed ID: 4860736
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
    Knopf B; Wätzig V; Knöll B
    Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Delayed immunity in bronchial cancer: lymphocyte activation in culture with phytohemagglutinins and tuberculin PPD compared with the skin response to tubercular antigens].
    Piacentini G; Ferrari S; Megale C; Ippoliti F
    Boll Ist Sieroter Milan; 1973; 52(3):230-6. PubMed ID: 4762779
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of levamisole on the tuberculin test.
    Vanella LM; González Lascano AM; Míguez VM
    Allergol Immunopathol (Madr); 1981; 9(2):103-8. PubMed ID: 6794341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)].
    Dundalek E
    Prax Klin Pneumol; 1980 Dec; 34(12):719-23. PubMed ID: 7465532
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunotherapy in bronchogenic carcinoma: effects on cellular immunity.
    Takita H; Han T; Marabella P
    Surg Forum; 1974; 25(0):235-6. PubMed ID: 4439174
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy-cum-radiotherapy-cum-surgery in the treatment of small-cell bronchogenic carcinoma (author's transl)].
    Gatzemeier U
    Prax Klin Pneumol; 1980 Feb; 34(2):102-7. PubMed ID: 7378158
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy.
    James DG
    Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(4):468-73. PubMed ID: 364779
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunological studies and immunotherapeutic possibilities in inoperable bronchogenic carcinoma (author's transl)].
    Titscher R; Micksche M
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():371-2. PubMed ID: 461311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low doses of chemotherapy to inhibit suppressor T cells.
    Berd D
    Prog Clin Biol Res; 1989; 288():449-58. PubMed ID: 2566177
    [No Abstract]   [Full Text] [Related]  

  • 16. Leishmania mexicana in C3H mice: BCG and levamisole treatment of established infections.
    Grimaldi GF; Moriearty PL; Hoff R
    Clin Exp Immunol; 1980 Aug; 41(2):237-42. PubMed ID: 7438553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCG, levamisole and transfer factor in the treatment of cancer.
    Spitler LE
    Prog Exp Tumor Res; 1980; 25():178-92. PubMed ID: 6986631
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
    Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the efficiency of the immune system after immunostimulation in patients with breast cancer].
    Scheller S; Mikolajski K; Rozek-Lesiak K; Koziol M
    Strahlentherapie; 1983 Oct; 159(10):615-21. PubMed ID: 6417841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunologic disorders in lung malignancies and possibilities of immuno-corrective therapy].
    Vucković Lj; Stanojević N; Rajner L; Susnjar S
    Glas Srp Akad Nauka Med; 1991; (41):87-96. PubMed ID: 1916451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.